Cytokinetics Shares Down 30.8% Since SmarTrend's Sell Call (CYTK)
February 03, 2016 at 19:25 PM EST
SmarTrend identified a Downtrend for Cytokinetics (NASDAQ:CYTK) on December 29th, 2015 at $10.44. In approximately 1 month, Cytokinetics has returned 30.81% as of today's recent price of $7.22.In the...